Loading clinical trials...
Loading clinical trials...
A Double-Blind Placebo-Controlled Trial of the Synbiotic Compound Probio-Tec ABCG for Schizophrenia Patients With and Without Elevated Markers of Gastrointestinal Inflammation
Conditions
Interventions
Synbiotic Supplement
Inert Compound
Locations
1
United States
Sheppard Pratt Health System
Batlimore, Maryland, United States
Start Date
February 21, 2022
Primary Completion Date
March 1, 2027
Completion Date
December 1, 2027
Last Updated
April 7, 2026
NCT06894212
NCT05240976
NCT06745479
NCT07455929
NCT05304767
NCT06740383
Lead Sponsor
Sheppard Pratt Health System
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions